Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 21,858 | 19,815 | 20,403 | 19,429 | 25,126 |
| Operating Income | -21,858 | -19,815 | -20,403 | -19,429 | -25,126 |
| Other Income | 2,263 | 2,519 | 2,748 | 2,861 | 3,430 |
| Pre-tax Income | -19,595 | -17,296 | -17,655 | -16,568 | -21,696 |
| Net Income Continuous | -19,595 | -17,296 | -17,655 | -16,568 | -21,696 |
| Net Income | $-19,595 | $-17,296 | $-17,655 | $-16,568 | $-21,696 |
| EPS Basic Total Ops | -0.31 | -0.28 | -0.28 | -0.27 | -0.35 |
| EPS Basic Continuous Ops | -0.31 | -0.28 | -0.28 | -0.27 | -0.35 |
| EPS Diluted Total Ops | -0.31 | -0.28 | -0.28 | -0.25 | -0.35 |
| EPS Diluted Continuous Ops | -0.31 | -0.28 | -0.28 | -0.25 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.28 | -0.28 | -0.31 | -0.35 |
| EBITDA(a) | $-21,512 | $-19,471 | $-20,050 | $-19,060 | $-24,757 |